Evidence that LiCl enhancement of the survival of NZB/W lupus mice is not mediated by alpha-melanocyte stimulating hormone

Journal of Trace and Microprobe Techniques

Volumn 16, Issue 1, 1998, Pages 111-118

  Hart, David A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

LiCl and survival; Murine models of SLE; MSH and murine lupus

Indexed keywords

EID: 0344459353     PISSN: 07334680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Catania A, Lipton JM (1993) Alpha-melanocyte stimulating hormone peptides in host responses. Ann. NY Acad. Sci. 680, 412-423.
2. Catania A, Lipton JM (1994) The neuropeptide alpha-melanocyte stimulating hormone: a key component of neuroimmunomodulation. Neuroimmunomodulation 1, 93-99.
3. Ceriani D, Diaz J, Murphree S, Catania A, Lipton JM (1994) The neuropeptide alpha-melanocyte stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1, 28-32.
4. Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332, 1351-1362.
5. Done SJ, Lenz SP, Benediktsson H, Fritzler MJ, Martin L, Krause G, Zhao P, Hart DA (1994) The effect of lithium on murine models of lupus nephritis. Lab. Invest, 7, 156A.
6. Dorr RT, Dawson B, Al-Obeidi F, Hadley ME, Levine N, Hruby VJ (1988) Toxicologic studies of a superpotent a-melanotropin, [Nie (4), D-Phe (7)] α-MSH. Investigational New Drugs 6, 251-258.
7. Dupont A, Kastin AJ, Labrie F, Pelletier G, Puviani R, Schally V (1975) Distribution of radioactivity in the organs of the rat and mouse after injection of [125-I]α-melanocyte-stimulating hormone. J. Endocrin. 64, 237-241.
8. Grabbe S, Bhardwaj R, Mahnke K, Simon M, Schwarz T, Luger TA (1996) Alpha-melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J. Immunol. 156, 473-478.
9. Hart DA, Done SJ, Benediktsson H, Lenz SP (1994) Partial characterization of the enhanced survival of female NZB/W mice treated with lithium chloride. Int. J. Immunopharmacol. 16, 825-833.
10. Hart DA, Lenz SP (1997) Influence of gender and timing of initiation of treatment on LiCl enhancement of NZB/W survival. J. Trace Microprobe Techniques 15, 101-107.
11. Hart DA, Lenz SP (1997) Multiple daily injections of NZBAV mice with LiCl leads to the long-term survival of a high percentage (80%) of the animals. J. Trace Microprobe Techniques, 15, 219-227.
12. Hu Y, Dietrich H, Herold M, Heinrich P, Wick G (1993) Disturbed immuno-endocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Int. Arch. Allergy Immunol. 102, 232-241.
13. Jorgensen C, Sany J (1994) Modulation of the immune response by the neuroendocrine axis in rheumatoid arthritis. Clin. Exp. Rheumatol. 12, 435-441.
14. Kono DH, Theofilopoulos AN (1996) Genetic contributions to SLE. J. Autoimmunity 9, 437-452.
15. Krause G, Zhao P, Martin L, Fritzler MJ, Benediktsson H, Hart DA (1992) LiCl prolongs survival and alters disease progression in the NZBAV model of SLE. Lithium 3, 61-67.
16. Lenz SP, Izui S, Benediktsson H, Hart DA (1995) LiCl enhances survival of NZBAV mice: influence of melatonin and timing of treatment. Int. J. Immunopharmacol. 17, 581-592.
17. Lenz SP, Hart DA (1997) LiCl treatment of female NZBAV mice leads to alteration in gene expression in renal tissue. J. Trace Microprobe Techniques 15, 117-125.
18. Lenz SP, Izui S, Hart DA (1997) Evidence that lithium chloride treatment of female NZBAV mice does not influence autoantibody profiles in this murine model of systemic lupus erythematosus. J. Trace Microprobe Techniques 15, 109-116.
19. Star RA, Rajora N, Huang J, Stock R, Catania A, Lipton JM (1995) Evidence of automne modulation of macrophage nitric oxide synthase by a-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. (USA) 92, 8016-8020.
20. Tatro JB, Reichlin S (1987) Specific receptors for a-melanocyte-stimulating hormone are widely distributed in tissues of rodents. Endocrinology 121, 1900-1907.
21. Taylor AW, Streilien JW, Cousins SW (1992) Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Current Eye Res. 11, 1199-1206.
22. Theofilopoulos AN, Dixon FJ (1987) Experimental murine systemic lupus erythematosus. In: Systemic lupus erythematosus, RG Lahita ed., John Wiley and Sons, New York, pp. 121-202.
23. .Turnbull AV, Rivier C (1995) Regulation of the HPA axis by cytokines. Brain, Behavior Immunity 9, 253-275.